tiprankstipranks
Coya Therapeutics, Inc. (COYA)
NASDAQ:COYA
US Market
COYA
Coya Therapeutics, Inc.
RESEARCH TOOLSreports

Coya Therapeutics, Inc. (COYA) Stock News & Sentiment

115 Followers
Coya Therapeutics Announces Leadership Changes and New Director
Premium
Company Announcements
Coya Therapeutics Announces Leadership Changes and New Director
8d ago
8K
COYA
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
18d ago
COYA
CTMX
Coya Therapeutics: Advancing Treg-Focused Pipeline with Near-Term Catalysts in ALS and FTD Supporting Buy Rating
Premium
Ratings
Coya Therapeutics: Advancing Treg-Focused Pipeline with Near-Term Catalysts in ALS and FTD Supporting Buy Rating
18d ago
COYA
Aggressive Treg-Modulating Immunology Strategy and Advancing Clinical Execution Underpin Buy Rating on Coya in ALS and FTD
Premium
Ratings
Aggressive Treg-Modulating Immunology Strategy and Advancing Clinical Execution Underpin Buy Rating on Coya in ALS and FTD
24d ago
COYA
Coya Therapeutics Announces Strategic Private Placement Financing
Premium
Company Announcements
Coya Therapeutics Announces Strategic Private Placement Financing
2M ago
8K
COYA
Coya Therapeutics Reports Strong Cash Position and Runway
Premium
Company Announcements
Coya Therapeutics Reports Strong Cash Position and Runway
3M ago
8K
COYA
COYA-302: De-Risked Treg Platform With Compelling FTD Data and ALS Phase 2 Catalyst Supporting Buy Rating
Premium
Ratings
COYA-302: De-Risked Treg Platform With Compelling FTD Data and ALS Phase 2 Catalyst Supporting Buy Rating
3M ago
COYA
More COYA News >

COYA News on the Web

Coya Therapeutics announces publication of research on COYA 302
TipRanks News
Neutral
Coya Therapeutics Announces Leadership Changes and New Director
TipRanks News
Neutral
Coya Therapeutics Executive Chairman Howard Berman steps down
TipRanks News
Bullish
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
TipRanks News
Neutral
Coya Therapeutics: Advancing Treg-Focused Pipeline with Near-Term Catalysts in ALS and FTD Supporting Buy Rating
TipRanks News
Bullish
Coya publishes study showing reduction in regulatory T cell function in FTD
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Immutep Ltd (OtherPRRUF), Coya Therapeutics, Inc. (COYA) and Rapport Therapeutics, Inc. (RAPP)
TipRanks News
Bullish
Aggressive Treg-Modulating Immunology Strategy and Advancing Clinical Execution Underpin Buy Rating on Coya in ALS and FTD
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
COYA
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.25 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is COYA’s Media Buzz Sentiment?
1 articles about COYA were published this week. In an average week, 2.25 articles are published.
    What is COYA’s weekly average amount of articles?
    In an average week, 2.25 articles about COYA are published.
      What is COYA’s News Sentiment?
      50% of articles about COYA were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        AORTArtivion
        OWLTOwlet
        STAAStaar Surgical
        ORGOOrganogenesis Holdings
        Showing the stocks with the most bullish news sentiment over the past week